Paid Clinical Trials in Texas

Texas has 5,485 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

State

City

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

5,485 clinical trials

↓ Download CSV

A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy

for Phase 1b

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07633756·Phase 1·Not Yet Recruiting

Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms

for Phase II

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07549451·Phase 2·Not Yet Recruiting

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

for ACT-GEN

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Female·Age: 18+

Code: NCT07565467·Not Yet Recruiting

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

for Barrett Esophagus

6 locations incl. Kansas City

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06732388·Phase 2·Not Yet Recruiting

SCIPI Implementation and Evaluation: A Multi-site Proof-of-Concept Pilot Trial

for Prostate Cancer

1 location in San Antonio

Sponsor: The University of Texas Health Science Center at San Antonio

Sex: All·Age: 18+

Code: NCT07280897·Not Yet Recruiting

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

for Prostate Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: Male·Age: 18+

Code: NCT07377006·Not Yet Recruiting

A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma

for Metastatic Olfactory Neuroblastoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07527169·Phase 2·Not Yet Recruiting

Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia

for Acute Myeloid Leukemia

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07549464·Phase 1·Not Yet Recruiting

Phase 2 Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

for Hodgkin Lymphoma

Drug: Nivolumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 2 - 21

Code: NCT07551583·Phase 2·Not Yet Recruiting

Phase 1b Study Of TRICK-NK In Combination With T-Dxd In Treatment-Refractory Breast Cancers

for Breast Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07553390·Phase 1·Not Yet Recruiting

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

for Clear Cell Renal Cell Carcinoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18 - 70

Code: NCT07564232·Phase 1·Not Yet Recruiting

Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

for Lymphocytic Leukemia

Drug: Mosunetuzumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07566364·Phase 2·Not Yet Recruiting

OCRA Distress & Unmet Needs

for Gynecologic Cancer

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07591623·Not Yet Recruiting

To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome

for Rett Syndrome

14 locations incl. Phoenix

Sponsor: Biomed Industries, Inc.

Sex: Female·Age: 5 - 20

Code: NCT06840496·Phase 3·Recruiting

Apply to this trial

Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women and Their Healthcare Providers in Texas.

for HIV Prevention

1 location in Galveston

Sponsor: The University of Texas Medical Branch, Galveston

Sex: Female·Age: 18 - 99·Accepts healthy volunteers

Code: NCT06864689·EARLY_Phase 1·Not Yet Recruiting

Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer

for Anaplastic Thyroid Cancer

Drug: Cemiplimab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07470489·Phase 2·Not Yet Recruiting

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

for Ocular Hyperemia

1 location in Fort Worth

Sponsor: Alcon Research

Sex: All·Age: 18+

Code: NCT07578363·Phase 3·Not Yet Recruiting

Intraosseous Antibiotics for Osseointegration

for Osseointegration Infection

5 locations incl. Aurora

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT07621094·Not Yet Recruiting

Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia

for Phase 2 Study

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07192237·Phase 2·Not Yet Recruiting

Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

for Phase 2

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07511023·Phase 2·Not Yet Recruiting

Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening

for Evaluating

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07513116·Not Yet Recruiting

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism

for Irritability Associated With Autism Spectrum Disorder

Drug: KarXT

27 locations incl. Dothan

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 5 - 17

Code: NCT07284745·Phase 3·Not Yet Recruiting

Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study

for Lymphatic Reconstruction

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT06887205·Not Yet Recruiting

Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections

for Retinal Disease

1 location in San Antonio

Sponsor: iRenix Medical, Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05750589·Phase 3·Not Yet Recruiting

Pivotal Study of N-acetyl-L-leucine for CACNA1A

for CACNA1A

3 locations incl. Baltimore

Sponsor: IntraBio Inc

Sex: All·Age: 4+

Code: NCT07221292·Phase 3·Not Yet Recruiting

Increasing Treatment Access in Trauma Exposed Children: Developing an Adapted Step One Intervention (RCT)

for Trauma

1 location in Houston

Sponsor: The University of Texas Health Science Center, Houston

Sex: All·Age: 7 - 14·Accepts healthy volunteers

Code: NCT07396974·Not Yet Recruiting

Enhancing Attention in Elderly Using a Brain-Computer-Interface

for Mild Cognitive Impairment (MCI)

1 location in Austin

Sponsor: University of Texas at Austin

Sex: All·Age: 18 - 90·Accepts healthy volunteers

Code: NCT07441122·Not Yet Recruiting

A Phase 2 Trial Of The Bruton Tyrosine Kinase Degrader BGB-16673 In Combination With BCL-2 Inhibitor Sonrotoclax For Patients With Treatment-Naive Chronic Lymphocytic Leukemia (CLL)

for Chronic Lymphocytic Leukemia (CLL)

Drug: Sonrotoclax

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07508995·Phase 2·Not Yet Recruiting

Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum

for Gastric Cancer, Metastatic

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07509008·Phase 1, Phase 2·Not Yet Recruiting

PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma

for Melanoma

Drug: Cemiplimab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07511036·Phase 2·Not Yet Recruiting

Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma

for T-cell Acute Lymphoblastic Leukemia

Drug: Daratumumab

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 12 - 30

Code: NCT07513129·Phase 1·Not Yet Recruiting

GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT)

for Atypical Teratoid Rhabdoid Tumor

1 location in Houston

Sponsor: Baylor College of Medicine

Sex: All·Age: 1 - 21

Code: NCT07513194·Phase 1·Not Yet Recruiting

Erlotinib for Hepatocellular Carcinoma Chemoprevention

for Cirrhosis, Liver

Drug: Erlotinib

1 location in Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18+

Code: NCT04172779·Phase 2·Not Yet Recruiting

Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum

for Obsessive-Compulsive Disorder (OCD)

2 locations incl. Providence

Sponsor: Baylor College of Medicine

Sex: All·Age: 18 - 64

Code: NCT05422469·Not Yet Recruiting

Transcutaneous Vagus Nerve Stimulation for Attention and Memory

for Traumatic Brain Injury (TBI) Patients

2 locations incl. Houston

Sponsor: Baylor College of Medicine

Sex: All·Age: 25 - 64

Code: NCT06723743·Recruiting

Apply to this trial

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

for Generalized Myasthenia Gravis

Drug: Inebilizumab

1 location in Austin

Sponsor: Amgen

Sex: All·Age: 2 - 17

Code: NCT06987539·Phase 2·Recruiting

Apply to this trial

Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure

for Heart Failure

2 locations incl. Dallas

Sponsor: University of Texas Southwestern Medical Center

Sex: All·Age: 18 - 100

Code: NCT07018297·Phase 3·Not Yet Recruiting

Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia

for Acute Myeloid Leukemia

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07411586·Phase 1·Not Yet Recruiting

Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma

for Leptomeningeal Melanoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07414979·Phase 1·Not Yet Recruiting

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

for Melanoma

1 location in Houston

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT07444606·Phase 1·Not Yet Recruiting